{
  "id": 5140099,
  "title": "FTC Bureau of Competition Director Statement Regarding Fairfield Medical Center’s Sale to Adena Health",
  "url": "https://urgent.news/2026/09/02/ftc-bureau-of-competition-director-statement-regarding-fairfield",
  "topic": "business",
  "section": "Business",
  "published": "2026-09-02T12:00:00.000Z",
  "source": {
    "name": "FTC Competition",
    "slug": "ftc-competition",
    "url": "https://www.ftc.gov/news-events/news/press-releases/2026/09/ftc-bureau-competition-director-statement-regarding-fairfield-medical-centers-sale-adena-health"
  },
  "original_language": "en",
  "account": "On September 1, 2026, Adena Health announced its acquisition of Fairfield Medical Center (FMC), a hospital system located in southeastern Ohio. This acquisition came after a Federal Trade Commission (FTC) investigation of a prior attempt by OhioHealth to acquire FMC. The FTC's investigation raised significant concerns about the competition implications of the proposed deal, as it could potentially increase costs and lower the quality of care for Ohio residents. Additionally, the investigation questioned the thoroughness of FMC's process for identifying potential buyers.\n\nUpon completing its investigation, the FTC closely worked with the Ohio Attorney General's Office. Encouraged by these findings, FMC explored alternative potential buyers through a comprehensive sales process, which ultimately attracted interest from multiple parties. This led to the cessation of the OhioHealth/FMC proposal and the subsequent partnership between FMC and Adena Health. This partnership will enable FMC to continue serving its patients in Ohio in the long run, while avoiding the competitive risks associated with the previous OhioHealth deal.\n\nFMC's decision to engage in a comprehensive sales process and ultimately partner with Adena Health exemplifies the FTC's commitment to rigorously enforcing antitrust laws and preserving competition in healthcare, particularly in rural communities across the United States. To highlight best practices for firms during the \"shopping\" process for a potential buyer, FTC Bureau of Competition Director Daniel Guarnera issued a statement alongside Commissioner Mark R. Meador. He emphasized that the FTC remains vigilant in safeguarding healthcare competition, particularly in the case of hospital deals. Guarnera reminded firms that the standard for a \"good\" deal is demanding and that if they have not thoroughly searched for potential buyers, the FTC will conduct an expedited investigation to determine if a more advantageous buyer exists. If deemed necessary, the Commission would take legal action to block a deal considered unfavorable. The Director expressed satisfaction that the FTC's diligent efforts resulted in a better outcome for Ohio's residents, FMC, and, most importantly, its patients and employees, without resorting to litigation.",
  "summary": "On Sept. 1, 2026, Adena Health announced its acquisition of Fairfield Medical Center (FMC), a hospital system in southeastern Ohio. The announcement follows a Federal Trade Commission investigation of an earlier attempt by a different acquirer—OhioHealth—to buy FMC. Commission staff’s investigation of OhioHealth’s proposed acquisition of FMC raised serious competitive concerns: the proposed…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "FTC Competition",
        "title": "Statement Regarding Fairfield Medical Center’s Sale to Adena Health",
        "url": "https://urgent.news/2026/09/02/statement-regarding-fairfield-medical-centers-sale-to-adena-health",
        "published": "2026-09-02T12:00:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}